On September 2, 2020 Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, reported that Michael Kauffman, MD, PhD, Chief Executive Officer of Karyopharm, will participate in a fireside chat at Baird’s 2020 Global Healthcare Conference and at the Morgan Stanley 18th Annual Global Healthcare Conference (Press release, Karyopharm, SEP 2, 2020, View Source [SID1234564318]). Details regarding these September conferences are below.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Baird’s 2020 Global Healthcare Conference
Date: Wednesday, September 9
Time: 10:15 AM ET

Morgan Stanley’s 18th Annual Global Healthcare Conference
Date: Tuesday, September 15
Time: 5:00 PM ET

A live webcast of the fireside chats can be accessed under "Events & Presentations" in the Investor section of the Company’s website, View Source A replay of the webcast will be archived on the Company’s website for 90 days following each fireside chat.